HUM Humana
- 356.200
- +1.010+0.28%
- 355.490
- -0.710-0.20%
Humana News
The Medicare Bubble Has Burst -- Heard on the Street -- WSJ
By David Wainer For years, the privately run Medicare Advantage business generated outsize profit growth for health-insurance giants. With hundreds of billions of taxpayer dollars flowing to insurer
Starboard Value Top Q1 Boosts, Cuts: Salesforce, Wix.com, Vertiv, Others
CenterWell Specialty Pharmacy Wins National Patient Choice Award
Organization recognized for the Sixth Time in Seven Years CenterWell Specialty Pharmacy has received the MMIT Specialty Pharmacy Patient Choice Award in the PBM/Payer category for the sixth time in seven years. The
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who
Humana: Hold Rating Amid Short-Term Pressures and Long-Term Optimism
If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,200 Today
Humana (NYSE:HUM) has outperformed the market over the past 20 years by 8.53% on an annualized basis producing an average annual return of 16.65%. Currently, Humana has a market capitalization of $40.
Humana Appoints Jim Rechtin as President and CEO
Humana Inc. Announces CEO Transition and Advisory Role Shifts
Humana Announces Jim Rechtin Will Assume The Role Of CEO On July 1, 2024, Bruce Broussard To Resign
Leading health insurer and health care services company Humana Inc. (NYSE:HUM) announced today that Jim Rechtin will assume the role of President and Chief Executive Officer effective July 1, 2024. As
Humana: Bruce Broussard Will Resign From Bd of Directors Effective July 1 >HUM
Humana: Bruce Broussard Will Resign From Bd of Directors Effective July 1 >HUM
Jim Rechtin to Assume Humana CEO Role Effective July 1, 2024
Leading health insurer and health care services company Humana Inc. (NYSE: HUM) announced today that Jim Rechtin will assume the role of President and Chief Executive Officer effective July 1, 2024.
Chris Davis Amplifies Stake in Humana Inc, Marking a Strategic Portfolio Shift
CVS Stock Is Dirt Cheap. That Doesn't Make It a Buy. -- Barrons.com
By Ian Salisbury Shares of CVS Health just went on sale. But like Valentine's candy in March, just because something is cheap, that doesn't make it a good buy. Shares of the convenience-store-turned
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.
$100 Invested In This Stock 20 Years Ago Would Be Worth $2,000 Today
Humana (NYSE:HUM) has outperformed the market over the past 20 years by 8.1% on an annualized basis producing an average annual return of 16.14%. Currently, Humana has a market capitalization of $38.4
Humana Names Successor to Outgoing President/CEO
Nordic care company Humana (HUM.ST) appointed Nathalie Boulas Nilsson as its new president and chief executive officer, effective July 22. Nilsson will succeed outgoing President and CEO Johanna Rasta
CVS Stock Discovers a Medicare Disadvantage -- Barrons.com
By Josh Nathan-Kazis and Jack Denton CVS Health caught a bad case of the Medicare Advantage blues this past week, blaming the program for its failure to meet quarterly-earnings expectations and slash
4 HMO Stocks to Watch Amid Persistent Industry Challenges
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.
Humana Up Nearly 6%, on Pace for Largest Percent Increase Since September 2022 -- Data Talk
Humana Inc. (HUM) is currently at $319.91, up $17.82 or 5.9% --Would be highest close since April 23, 2024, when it closed at $327.98 --On pace for largest percent increase since Sept. 15, 2022, whe
Analysis
Price Target
No Data
